Concepedia

Martina Kovac

MK

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

2005

Affiliations

GlaxoSmithKline (Belgium)(Current)

Westmead Institute for Medical Research

Dalhousie University

The University of Sydney

GlaxoSmithKline (United States)

Martina Kovac is an author at GlaxoSmithKline (Belgium) specializing in vaccinology, vaccination, and veterinary medicine.

Publications per year

2005–2022

11

Publications

11

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

, , +17

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

Janet E. McElhaney, Jeanne‐Marie Devaster, Meral Esen et al. · The Lancet Infectious Diseases · 2013 · 165 citations

, , +16

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 65 citations · Full text

, , +17

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial

Olivier Godeaux, Martina Kovac, Daniel Shu et al. · Human Vaccines & Immunotherapeutics · 2017 · 53 citations · Full text

, , +17

Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials

Martina Kovac, Himal Lal, Anthony L. Cunningham et al. · Vaccine · 2018 · 45 citations · Full text

, , +17

1–5 of 11